Wantong Yao

8PUBLICATIONS
98CO-AUTHORS
Molecular targetsCancer cell biologyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 11, 2026
All-trans retinoic acid destabilizes ADAR1 protein through retinoylation-mediated USP7 dissociation and improves immunotherapy in pancreatic cancer.

|Apr 06, 2026
DPY30 Is an Epigenetic Decoupler Linking Replication Stress to Immunoediting in Pancreatic Cancer.

Francesca Citron, Luca Cecchetto, Elisabetta Granato

|Dec 02, 2025
GFER Represents a Target for Dual Disruption of Redox Homeostasis and Reactivation of the Immune Response in Pancreatic Adenocarcinoma.

Ziheng Chen, I-Lin Ho, Jintan Liu

|Sep 18, 2025
KRAS Inhibition Activates an Actionable CD24 "Do Not Eat Me" Signal in Pancreatic Cancer.

Yongkun Wei, Minghui Liu, Er-Yen Yen

|Nov 01, 2024
WRAD core perturbation impairs DNA replication fidelity promoting immunoediting in pancreatic cancer.

Francesca Citron, I-Lin Ho, Chiara Balestrieri

|Jun 10, 2024
Lysophosphatidylcholine acyltransferase 1 suppresses nanoclustering and function of KRAS.

Neha Arora, Hong Liang, Wantong Yao

Pageof 2

Frequent Collaborators

5 joint publications

Er-Yen Yen

5 joint publications

Andrea Viale

5 joint publications

Haoqiang Ying

4 joint publications

I-Lin Ho